136 related articles for article (PubMed ID: 2464269)
1. Myelin basic protein as a possible marker for oligodendroglioma.
Tanaka J; Hokama Y; Nakamura H
Acta Pathol Jpn; 1988 Oct; 38(10):1297-303. PubMed ID: 2464269
[TBL] [Abstract][Full Text] [Related]
2. [MBP and GFAP immunohistochemistry of oligodendrogliomas with relationship to myelin-forming glia in cell differentiation].
Hokama Y; Tanaka J; Nakamura H; Hori T
No To Shinkei; 1986 Apr; 38(4):379-86. PubMed ID: 2424482
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical characterization of oligodendrogliomas: an analysis of multiple markers.
Nakagawa Y; Perentes E; Rubinstein LJ
Acta Neuropathol; 1986; 72(1):15-22. PubMed ID: 2435103
[TBL] [Abstract][Full Text] [Related]
4. Glial fibrillary acidic protein (GFAP) in oligodendroglial tumors: gliofibrillary oligodendroglioma and transitional oligoastrocytoma as subtypes of oligodendroglioma.
Herpers MJ; Budka H
Acta Neuropathol; 1984; 64(4):265-72. PubMed ID: 6391068
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological study of oligodendroglioma with special reference to immunohistochemical investigation].
Kubo O; Tajika Y; Toyama T; Tajika T; Sakairi M; Katahira M; Kitamura K
No Shinkei Geka; 1988 Aug; 16(9):1029-35. PubMed ID: 2462693
[TBL] [Abstract][Full Text] [Related]
6. CD44 expression in primary and recurrent oligodendrogliomas and in adjacent gliotic brain tissue.
Hagel C; Stavrou DK
Neuropathol Appl Neurobiol; 1999 Aug; 25(4):313-8. PubMed ID: 10476048
[TBL] [Abstract][Full Text] [Related]
7. Oligodendroglioma with signet-ring cell morphology: a case report with an immunohistochemical and ultrastructural study.
Mikami Y; Shirabe T; Hata S; Watanabe A
Pathol Int; 1998 Feb; 48(2):144-50. PubMed ID: 9589479
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of ABCA2' a possible molecular marker for oligodendrogliomas.
Soichi O; Masanori N; Hideo T; Kazunori A; Nobuya I; Jun-ichi K
Neurosurgery; 2007 Apr; 60(4):707-14; discussion 714. PubMed ID: 17415208
[TBL] [Abstract][Full Text] [Related]
9. Mixed oligodendroglioma and astrocytoma: fine structural and immunohistochemical studies of four cases.
Kamitani H; Masuzawa H; Sato J; Kanazawa I
J Neurol Sci; 1988 Feb; 83(2-3):219-25. PubMed ID: 2451711
[TBL] [Abstract][Full Text] [Related]
10. GFAP-positive and myelin marker-positive glia in normal and pathologic environments.
Dyer CA; Kendler A; Jean-Guillaume D; Awatramani R; Lee A; Mason LM; Kamholz J
J Neurosci Res; 2000 May; 60(3):412-26. PubMed ID: 10797544
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic characteristics of GFAP-positive oligodendroglial tumours. Part II: ultrastructural study.
Matyja E; Taraszewska A; Nagańska E; Zabek M
Folia Neuropathol; 2001; 39(2):103-10. PubMed ID: 11680631
[TBL] [Abstract][Full Text] [Related]
12. [Expression of myelin basic protein and glial fibrillary acidic protein genes in human glial brain tumors].
Dmytrenko VV; Boĭko OI; Shostak KO; Bilets'kyĭ AV; Malysheva TA; Shamaiev MI; Kliuchka VM; Rozumenko VD; Zozulia IuP; Kavsan VM
Tsitol Genet; 2009; 43(1):28-35. PubMed ID: 19663312
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic characteristics of GFAP-immunopositive oligodendroglial tumours Part I: immunohistochemical study.
Matyja E; Taraszewska A; Zabek M
Folia Neuropathol; 2001; 39(1):19-26. PubMed ID: 11678347
[TBL] [Abstract][Full Text] [Related]
14. YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas.
Nutt CL; Betensky RA; Brower MA; Batchelor TT; Louis DN; Stemmer-Rachamimov AO
Clin Cancer Res; 2005 Mar; 11(6):2258-64. PubMed ID: 15788675
[TBL] [Abstract][Full Text] [Related]
15. Astrocytic characteristics of oligodendroglioma. Fine structural and immunohistochemical studies of two cases.
Kamitani H; Masuzawa H; Sato J; Kanazawa I
J Neurol Sci; 1987 May; 78(3):349-55. PubMed ID: 3585407
[TBL] [Abstract][Full Text] [Related]
16. Expression of oligodendrocytic mRNAs in glial tumors: changes associated with tumor grade and extent of neoplastic infiltration.
Landry CF; Verity MA; Cherman L; Kashima T; Black K; Yates A; Campagnoni AT
Cancer Res; 1997 Sep; 57(18):4098-104. PubMed ID: 9307299
[TBL] [Abstract][Full Text] [Related]
17. Nogo-A expression in oligodendroglial tumors.
Jung TY; Jung S; Lee KH; Cao VT; Jin SG; Moon KS; Kim IY; Kang SS; Kim HS; Lee MC
Neuropathology; 2011 Feb; 31(1):11-9. PubMed ID: 20487307
[TBL] [Abstract][Full Text] [Related]
18. Evidence for central nervous system glial cell plasticity in phenylketonuria.
Dyer CA; Kendler A; Philibotte T; Gardiner P; Cruz J; Levy HL
J Neuropathol Exp Neurol; 1996 Jul; 55(7):795-814. PubMed ID: 8965095
[TBL] [Abstract][Full Text] [Related]
19. An immunocytochemical comparison of the glia-associated proteins glial fibrillary acidic protein (GFAP) and S-100 protein (S100P) in human brain tumors.
Kimura T; Budka H; Soler-Federsppiel S
Clin Neuropathol; 1986; 5(1):21-7. PubMed ID: 3512139
[TBL] [Abstract][Full Text] [Related]
20. An immunocytochemical comparison of glial fibrillary acidic protein, S-100p and vimentin in human glial tumors.
Nakopoulou L; Kerezoudi E; Thomaides T; Litsios B
J Neurooncol; 1990 Feb; 8(1):33-40. PubMed ID: 2319288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
